Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| Allomeetriline farmakokineetiline skaalimine× | Michaelis-Menteni kineetika× | |
|---|---|---|
| Valdkond | Farmakoloogia | Farmakoloogia |
| Perekond | Process / pipeline | Process / pipeline |
| Tekkeaasta≠ | 1989 | 1913 |
| Looja≠ | John Mordenti | Leonor Michaelis and Maud Menten |
| Tüüp≠ | inter-species extrapolation | mechanistic model |
| Algallikas≠ | Mordenti, J., & Chappell, W. (1989). The use of allometric scaling in toxicokinetic studies. Fundamental and Applied Toxicology, 13(2), 335-346. link ↗ | Michaelis, L., & Menten, M. L. (1913). Die Kinetik der Invertinwirkung. Biochemische Zeitschrift, 49, 333-369. link ↗ |
| Rööpnimetused | allometric scaling, inter-species extrapolation, FIH dose prediction | MM kinetics, Michaelis constant, Vmax |
| Seotud≠ | 3 | 2 |
| Kokkuvõte≠ | Allometric scaling is a mathematical approach for predicting human pharmacokinetics from preclinical animal data using body weight relationships. Developed systematically by Mordenti and colleagues in the late 1980s, it enables rational first-in-human dose prediction without assuming species-specific metabolic differences. | Michaelis-Menten kinetics describes the rate of enzyme-catalyzed reactions as a function of substrate concentration. Developed by Leonor Michaelis and Maud Menten in 1913, this foundational framework models enzyme catalysis through the rapid-equilibrium approximation and enables prediction of drug metabolism rates in pharmacokinetics. |
| ScholarGateAndmestik ↗ |
|
|